I'll be honnest and been around investing since the 70's. This style was common place back before all the interweb nonsense. LOL

I've sat through many sales pitches like this at my broker's offices and the snail mail hype was so common place through the 80's and 90's. Its was the biggest reason I even watched the spill due to its use now. Commical to say the least. That was a lot of effort to put together to sell some subscription. I was sort of shocked and made me watch to see this style of pump comming from I-Hub.

So I had to go digging. CXSP does have some heavy hitters imbedded within their PRs.

Don't know about MITI, I'm a Chemgenex investor, that's how I found this posting.

Yes, it's very very cheesy! In fact, text book bull s%!t marketing for high risk stock.

Seems they are doing a capital raising, thus they need the cash (hence the promotion).

Welcome aboard! Nice first post, Guess I can't take a hint.
You migh have nailed it! Bethesda, Maryland (Corporate Headquarters)
MITI....is it worth a shit company?

But ya gotta admit its a cheesy way to be used to sell some lame subscription,
Thanks for keeping us on track. See ya over on the correct thread.
Odd how these two are about the same?

Why are you posting this about Chemgenex ? The company is Micromet they are hinting to???

Scottrade gives me an O/S of a mere 19MM shares
I'll try a call to the T/A if they even have one that speaks.


http://www.google.com/finance?client=ob&q=NASDAQ:CXSPY

Company Background
ChemGenex Pharmaceuticals Limited (ChemGenex) is an integrated biopharmaceutical development company with specialize in the discovery and the development of oncology drugs. As of June 30, 2010, ChemGenex Pharmaceuticals Inc. and ChemGenex Europe SAS were 100% owned by ChemGenex Pharmaceuticals Limited. ChemGenex focuses on developing targeted medicines for the treatment of cancer by identifying and targeting the genetic components of a range of cancer types. The Company has two molecules in clinical development and has progressed its lead compound, omacetaxine, to regulatory submission in Europe and the United States. The Company has submitted Omacetaxine to United States and European regulators for approval in chronic myeloid leukemia (CML) patients who have failed the tyrosine kinase inhibitor (TKI) imatinib and have the T315I point mutation. ChemGenex's other development stage molecule Quinamed, has completed phase IIa clinical trials in a range of solid cancers.
..

Thanks I-hub for the spam tonight!



http://moneymappress.com/video/mmp/mmr/mmr-micro-1010.php?code=LMMRLB05

I'm sure they paid I-hub big bucks to pump this to sell some cheesy subscription in order to get this stock pick.


Doesn't take too long for a few of us to figure who the company is that the spam is talking about.
Watch the video and then let me know. Great pump till he starts to repeat himself and the massive run on thoughts hitting tangents with stringing a viewer along just to get to the punch line.
They project a 2000+% from todays $7.00 pps. Kinda cool if you believe. Time is said to be short on this play. I'd have to bear through the vid again to get an answer. Not sure I'm up for it after 4 beers.
Its on my watch list and major effort was put into pumping this. What sucks is the pitch to sell their subscription in order to get this pick. Not sure it takes away from the company or not.
Lousey promnoation to get folks looking at this company. Big red flag.
I'll be speaking with the company to see how they condone this promoation.
Could still be a great product if it hiunts out cancer and wiped em out. Big name pharma is all over this drug developer.
Could be the holy grain of cancer and other diesease treatments.
Keeping an eye on it.
Good Luck to all.
Fink